ArticleCell cycle (Georgetown, Tex.)2014

Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.

Melissa Sokolosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.